Crowley Michael
Known title: EVP, GBL Commercial OperationsCIK: 0001629381
Associated companies
Transaction History
| BIO | ▲ Buy | Option Exercise | 3,000 | $478K | 3/14/2025 | View on chart |
| BIO | ▼ Sell | Open Market | 3,000 | $741K | 3/14/2025 | View on chart |
| BIO | ▲ Buy | Option Exercise | 557 | $0 | 9/3/2024 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 283 | $95K | 9/3/2024 | View on chart |
| BIO | ▲ Buy | Option Exercise | 434 | $0 | 9/2/2024 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 155 | $52K | 9/2/2024 | View on chart |
| BIO | ▲ Buy | Option Exercise | 751 | $0 | 9/1/2024 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 268 | $90K | 9/1/2024 | View on chart |
| BIO | ▲ Buy | Option Exercise | 520 | $0 | 9/1/2024 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 218 | $74K | 9/1/2024 | View on chart |
| BIO | ▲ Buy | Option Exercise | 405 | $0 | 9/1/2024 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 145 | $49K | 9/1/2024 | View on chart |
| BIO | ▼ Sell | Open Market | 369 | $104K | 6/13/2024 | View on chart |
| BIO | ▲ Buy | Option Exercise | 3,000 | $648K | 2/27/2024 | View on chart |
| BIO | ▼ Sell | Open Market | 3,000 | $1.0M | 2/27/2024 | View on chart |
| BIO | ▼ Sell | Open Market | 642 | $196K | 11/28/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 600 | $0 | 9/4/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 298 | $118K | 9/4/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 557 | $0 | 9/3/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 202 | $80K | 9/3/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 433 | $0 | 9/2/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 150 | $59K | 9/2/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 520 | $0 | 9/1/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 180 | $71K | 9/1/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 405 | $0 | 9/1/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 141 | $56K | 9/1/2023 | View on chart |
| BIO | ▼ Sell | Open Market | 500 | $190K | 6/15/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 600 | $0 | 9/5/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 298 | $143K | 9/5/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 600 | $0 | 9/4/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 298 | $143K | 9/4/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 557 | $0 | 9/3/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 241 | $115K | 9/3/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 433 | $0 | 9/2/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 150 | $72K | 9/2/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 405 | $0 | 9/1/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 141 | $69K | 9/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth
The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth. The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.